Clinical Trial Update: An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated the efficacy and safety of long-acting injectable risperidone compared with oral risperidone in adults with schizophrenia; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Risperdal (risperidone)
• Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2014-03-11